GXFC3 (Combivir 150 mg / 300 mg)

Generic Name: lamivudine/zidovudine

This pill with imprint "GXFC3" is White, Elliptical / Oval and has been identified as Combivir 150 mg / 300 mg. It is supplied by GlaxoSmithKline.

Combivir is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Combivir

Generic Name:

lamivudine/zidovudine

Imprint:

GXFC3

Strength:

150 mg / 300 mg

Color:

White

Size:

17.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

GlaxoSmithKline

Inactive Ingredients:

silicon dioxide colloidal
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.